BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD, Keefer L, Lembo AJ, Parkman HP, Rao SS, Sperber A, Spiegel B, Tack J, Vanner S, Walker LS, Whorwell P, Yang Y. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016;150:1481-1491. [PMID: 27144634 DOI: 10.1053/j.gastro.2016.02.014] [Cited by in Crossref: 204] [Cited by in F6Publishing: 158] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Murray KA, Hoad CL, Garratt J, Kaviani M, Marciani L, Smith JK, Siegmund B, Gowland PA, Humes DJ, Spiller RC. A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis. PLoS One 2019;14:e0216528. [PMID: 31067253 DOI: 10.1371/journal.pone.0216528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Chang L. How to Approach a Patient with Difficult-to-Treat IBS. Gastroenterology 2021:S0016-5085(21)03285-6. [PMID: 34331916 DOI: 10.1053/j.gastro.2021.07.034] [Reference Citation Analysis]
3 Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6. [PMID: 29072609 DOI: 10.3390/jcm6110099] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 24.2] [Reference Citation Analysis]
4 Vallès M, Antuori A, Mearin F, Serra J. Small intestinal bacterial overgrowth in spinal cord injury patients. Gastroenterol Hepatol 2021:S0210-5705(21)00059-5. [PMID: 33640466 DOI: 10.1016/j.gastrohep.2021.01.010] [Reference Citation Analysis]
5 Hunt MG, Wong C, Aajmain S, Dawodu I. Fecal incontinence in people with self-reported irritable bowel syndrome: Prevalence and quality of life. J Psychosom Res 2018;113:45-51. [PMID: 30190047 DOI: 10.1016/j.jpsychores.2018.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
6 Potter M, Jones MP, Walker MM, Koloski NA, Keely S, Holtmann G, Talley Ac NJ. Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia. Med J Aust 2020;212:126-31. [PMID: 31909482 DOI: 10.5694/mja2.50458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 Whitaker LHR, Doust A, Stephen J, Norrie J, Cooper K, Daniels J, Hummelshoj L, Cox E, Beatty L, Chien P, Madhra M, Vincent K, Horne AW. Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1). Pilot Feasibility Stud 2021;7:19. [PMID: 33413677 DOI: 10.1186/s40814-020-00740-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48:1044-1060. [PMID: 30294792 DOI: 10.1111/apt.15001] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 37.5] [Reference Citation Analysis]
9 Zhang Y, Wu XX, Li S, Wu JF, Han S, Lin ZJ, Ding SZ, Gong WJ. Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13741. [PMID: 31613423 DOI: 10.1111/nmo.13741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M. Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study. Clinical Gastroenterology and Hepatology 2018;16:1252-1259.e5. [DOI: 10.1016/j.cgh.2018.02.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
11 Tan VP. The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia. J Gastroenterol Hepatol. 2017;32 Suppl 1:46-52. [PMID: 28244670 DOI: 10.1111/jgh.13697] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
12 Tai FWD, Palsson OS, Lam CY, Whitehead WE, Sperber AD, Tornblom H, Simren M, Aziz I. Functional gastrointestinal disorders are increased in joint hypermobility‐related disorders with concomitant postural orthostatic tachycardia syndrome. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Lam CY, Palsson OS, Whitehead WE, Sperber AD, Tornblom H, Simren M, Aziz I. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome. Clin Gastroenterol Hepatol 2021;19:277-287.e3. [PMID: 32109633 DOI: 10.1016/j.cgh.2020.02.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Leccioli V, Oliveri M, Romeo M, Berretta M, Rossi P. A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence. Nutrients 2017;9:E1203. [PMID: 29099090 DOI: 10.3390/nu9111203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
15 Black CJ, Craig O, Gracie DJ, Ford AC. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut 2021;70:1110-6. [PMID: 32973070 DOI: 10.1136/gutjnl-2020-322519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Luthy KE, Larimer SG, Freeborn DS. Differentiating Between Lactose Intolerance, Celiac Disease, and Irritable Bowel Syndrome-Diarrhea. The Journal for Nurse Practitioners 2017;13:348-53. [DOI: 10.1016/j.nurpra.2017.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Harpain F, Gasché C, Prager G, Silberhumer GR. A siphon-like retrogastric transverse colon: A case report. Int J Surg Case Rep 2018;44:110-3. [PMID: 29499513 DOI: 10.1016/j.ijscr.2018.01.009] [Reference Citation Analysis]
18 Meng Q, Qin G, Yao SK, Fan GH, Dong F, Tan C. Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study. World J Clin Cases 2021; 9(11): 2487-2502 [PMID: 33889614 DOI: 10.12998/wjcc.v9.i11.2487] [Reference Citation Analysis]
19 Murray HB, Pasricha TS, Jehangir A, Thomas JJ, Kuo B, Parkman HP. Detection and characteristics of rumination syndrome in patients presenting for gastric symptom evaluation. Neurogastroenterol Motil 2021;33:e14103. [PMID: 33729638 DOI: 10.1111/nmo.14103] [Reference Citation Analysis]
20 Chen L, Ilham SJ, Feng B. Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesth Pain Med 2017;7:e42747. [PMID: 28824858 DOI: 10.5812/aapm.42747] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
21 Midenfjord I, Grinsvall C, Koj P, Carnerup I, Törnblom H, Simrén M. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease. Neurogastroenterol Motil 2021;:e14156. [PMID: 33860970 DOI: 10.1111/nmo.14156] [Reference Citation Analysis]
22 Loosen SH, Jördens MS, Luedde M, Modest DP, Labuhn S, Luedde T, Kostev K, Roderburg C. Incidence of Cancer in Patients with Irritable Bowl Syndrome. J Clin Med 2021;10:5911. [PMID: 34945206 DOI: 10.3390/jcm10245911] [Reference Citation Analysis]
23 Goodoory VC, Houghton LA, Black CJ, Ford AC. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterol Motil 2021;:e14268. [PMID: 34532930 DOI: 10.1111/nmo.14268] [Reference Citation Analysis]
24 Shiha MG, Ashgar Z, Fraser EM, Kurien M, Aziz I. High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria. EClinicalMedicine 2020;25:100465. [PMID: 32954237 DOI: 10.1016/j.eclinm.2020.100465] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sood R, Ford AC. Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same? Nat Rev Gastroenterol Hepatol 2016;13:501-2. [PMID: 27407043 DOI: 10.1038/nrgastro.2016.110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
26 El-Salhy M, Hausken T, Gilja OH, Hatlebakk JG. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2017;11:139-148. [PMID: 27927062 DOI: 10.1080/17474124.2017.1269601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
27 Jacobs JP, Gupta A, Bhatt RR, Brawer J, Gao K, Tillisch K, Lagishetty V, Firth R, Gudleski GD, Ellingson BM, Labus JS, Naliboff BD, Lackner JM, Mayer EA. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome 2021;9:236. [PMID: 34847963 DOI: 10.1186/s40168-021-01188-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ballou S, Katon J, Rangan V, Cheng V, Nee J, Iturrino J, Lembo A. Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci 2020;65:3260-70. [DOI: 10.1007/s10620-020-06182-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries. American Journal of Gastroenterology 2018;113:86-96. [DOI: 10.1038/ajg.2017.421] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 16.5] [Reference Citation Analysis]
30 Southwell BR. Treatment of childhood constipation: a synthesis of systematic reviews and meta-analyses. Expert Rev Gastroenterol Hepatol 2020;14:163-74. [PMID: 32098515 DOI: 10.1080/17474124.2020.1733974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Arasteh P, Maharlouei N, Eghbali SS, Amini M, Lankarani KB, Malekzadeh R. A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort Study. Middle East J Dig Dis 2018;10:149-59. [PMID: 30186578 DOI: 10.15171/mejdd.2018.104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Seger S, Nasharuddin NNB, Fernandez SL, Yunus SRBM, Shun NTM, Agarwal P, Burud I. Prevalence and factors associated with irritable bowel syndrome among medical students in a Malaysian private university: a cross sectional study. Pan Afr Med J 2020;37:151. [PMID: 33425184 DOI: 10.11604/pamj.2020.37.151.21716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Duncanson K, Burrows T, Keely S, Potter M, Das G, Walker M, Talley NJ. The Alignment of Dietary Intake and Symptom-Reporting Capture Periods in Studies Assessing Associations between Food and Functional Gastrointestinal Disorder Symptoms: A Systematic Review. Nutrients 2019;11:E2590. [PMID: 31661839 DOI: 10.3390/nu11112590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
34 Holtmann GJ, Talley NJ. Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? Gut 2018;67:1911-5. [PMID: 29921653 DOI: 10.1136/gutjnl-2017-314775] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
35 Whitehead WE, Simren M, Busby-Whitehead J, Heymen S, van Tilburg MAL, Sperber AD, Palsson OS. Fecal Incontinence Diagnosed by the Rome IV Criteria in the United States, Canada, and the United Kingdom. Clin Gastroenterol Hepatol 2020;18:385-91. [PMID: 31154029 DOI: 10.1016/j.cgh.2019.05.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 2019;109:1098-111. [DOI: 10.1093/ajcn/nqy376] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
37 Schneider E, Sabaté JM, Bouchoucha M, Hercberg S, Touvier M, Benamouzig R, Julia C, Buscail C. Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Santé Cohort. Nutrients 2021;13:4513. [PMID: 34960065 DOI: 10.3390/nu13124513] [Reference Citation Analysis]
38 Goodoory VC, Craig OF, Gracie DJ, Black CJ, Ford AC. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study. Neurogastroenterol Motil 2021;:e14282. [PMID: 34612560 DOI: 10.1111/nmo.14282] [Reference Citation Analysis]
39 Santonicola A, Gagliardi M, Asparago G, Carpinelli L, Angrisani L, Iovino P. Anhedonia and functional dyspepsia in obese patients: Relationship with binge eating behaviour. World J Gastroenterol 2020; 26(20): 2632-2644 [PMID: 32523316 DOI: 10.3748/wjg.v26.i20.2632] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR. Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Aliment Pharmacol Ther 2017;45:824-32. [PMID: 28105700 DOI: 10.1111/apt.13949] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
41 Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med. 2018;60:213-222. [PMID: 30257542 DOI: 10.23736/s0031-0808.18.03541-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
42 Schulz C, Kalali B, Link A, Gerhard M, Malfertheiner P. New rapid Helicobacter pylori blood test based on dual detection of FliD and CagA antibodies for on-site testing. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01220-9. [PMID: 34793965 DOI: 10.1016/j.cgh.2021.11.008] [Reference Citation Analysis]
43 García-Carrasco M, Mendoza-Pinto C, Munguía-Realpozo P, Méndez-Valderrabano F, Méndez Martínez S, Etchegaray Morales I, Montiel-Jarquín Á, López-Colombo A, Schmulson M. Functional gastrointestinal disorders in women with systemic lupus erythematosus: A case-control study. Neurogastroenterol Motil 2019;31:e13693. [PMID: 31373090 DOI: 10.1111/nmo.13693] [Reference Citation Analysis]
44 Zickgraf HF, Loftus P, Gibbons B, Cohen LC, Hunt MG. "If I could survive without eating, it would be a huge relief": Development and initial validation of the Fear of Food Questionnaire. Appetite 2021;:105808. [PMID: 34798226 DOI: 10.1016/j.appet.2021.105808] [Reference Citation Analysis]
45 Hod K, Ringel Y, van Tilburg MAL, Ringel-Kulka T. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities. Dig Dis Sci 2019;64:1288-95. [PMID: 30565010 DOI: 10.1007/s10620-018-5352-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Buzás GM. Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018. Minerva Gastroenterol Dietol 2018;64:280-96. [PMID: 29458240 DOI: 10.23736/S1121-421X.18.02481-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
47 Huaman JW, Mego M, Bendezú A, Monrroy H, Samino S, Accarino A, Saperas E, Azpiroz F. Correction of Dyssynergic Defecation, but Not Fiber Supplementation, Reduces Symptoms of Functional Dyspepsia in Patients With Constipation in a Randomized Trial. Clin Gastroenterol Hepatol 2020;18:2463-2470.e1. [PMID: 31811952 DOI: 10.1016/j.cgh.2019.11.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chollet MB, Akin C. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes. Journal of Allergy and Clinical Immunology 2021. [DOI: 10.1016/j.jaci.2021.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 O' Mahony SM, Dinan TG, Cryan JF. The gut microbiota as a key regulator of visceral pain. Pain 2017;158:S19-28. [DOI: 10.1097/j.pain.0000000000000779] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
50 Laatikainen R, Salmenkari H, Sibakov T, Vapaatalo H, Turpeinen A. Randomised Controlled Trial: Partial Hydrolysation of Casein Protein in Milk Decreases Gastrointestinal Symptoms in Subjects with Functional Gastrointestinal Disorders. Nutrients 2020;12:E2140. [PMID: 32708428 DOI: 10.3390/nu12072140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Clevers E, Tran M, Van Oudenhove L, Störsrud S, Böhn L, Törnblom H, Simrén M. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition 2020;73:110719. [PMID: 32086111 DOI: 10.1016/j.nut.2020.110719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Sperber AD. Review article: epidemiology of IBS and other bowel disorders of gut-brain interaction (DGBI). Aliment Pharmacol Ther 2021;54 Suppl 1:S1-S11. [PMID: 34927754 DOI: 10.1111/apt.16582] [Reference Citation Analysis]
53 Barberio B, Houghton LA, Yiannakou Y, Savarino EV, Black CJ, Ford AC. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:362-71. [DOI: 10.14309/ajg.0000000000000946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
54 Murray HB, Juarascio AS, Di Lorenzo C, Drossman DA, Thomas JJ. Diagnosis and Treatment of Rumination Syndrome: A Critical Review. Am J Gastroenterol 2019;114:562-78. [PMID: 30789419 DOI: 10.14309/ajg.0000000000000060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
55 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Reference Citation Analysis]
56 Blot E, Raz M, Withall J, Link L, Rich E. The Effectiveness of a Senokot Cocktail for Postoperative Constipation. Orthop Nurs 2021;40:159-68. [PMID: 34004615 DOI: 10.1097/NOR.0000000000000756] [Reference Citation Analysis]
57 Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. Am J Gastroenterol 2021;116:372-81. [PMID: 33110014 DOI: 10.14309/ajg.0000000000000975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
58 Parker S, Palsson O, Sanders DS, Simren M, Sperber AD, Törnblom H, Urwin H, Whitehead W, Aziz I. Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00758-8. [PMID: 34298190 DOI: 10.1016/j.cgh.2021.07.026] [Reference Citation Analysis]
59 Meyer R, Fox AT, Chebar Lozinsky A, Michaelis LJ, Shah N. Non-IgE-mediated gastrointestinal allergies-Do they have a place in a new model of the Allergic March. Pediatr Allergy Immunol 2019;30:149-58. [PMID: 30403301 DOI: 10.1111/pai.13000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Ruddy J, Taft T, Siau K, Bollipo S. Emotional state should not be used to differentiate IBD from IBS. Lancet Gastroenterol Hepatol 2020;5:723. [PMID: 32673607 DOI: 10.1016/S2468-1253(20)30198-9] [Reference Citation Analysis]
61 Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S, Aziz I. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterol Motil 2021;33:e14121. [PMID: 33719130 DOI: 10.1111/nmo.14121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Jehangir A, Parkman HP. Rome IV Diagnostic Questionnaire Complements Patient Assessment of Gastrointestinal Symptoms for Patients with Gastroparesis Symptoms. Dig Dis Sci 2018;63:2231-43. [PMID: 29808246 DOI: 10.1007/s10620-018-5125-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
63 Goldstein RS, Cash BD. Making a Confident Diagnosis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:547-63. [PMID: 34304787 DOI: 10.1016/j.gtc.2021.03.004] [Reference Citation Analysis]
64 Sadrin S, Sennoune S, Gout B, Marque S, Moreau J, Zinoune K, Grillasca JP, Pons O, Maixent JM. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52:534-40. [PMID: 31952938 DOI: 10.1016/j.dld.2019.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Shah ED, Almario CV, Spiegel BMR, Chey WD. Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation. J Neurogastroenterol Motil 2018;24:299-306. [PMID: 29605985 DOI: 10.5056/jnm17112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
66 Poscente MD, Mintchev MP. Enhanced electrogastrography: A realistic way to salvage a promise that was never kept? World J Gastroenterol 2017; 23(25): 4517-4528 [PMID: 28740340 DOI: 10.3748/wjg.v23.i25.4517] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
67 Krammer H, Storr M, Madisch A, Riffel J. [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. Z Gastroenterol 2021;59:125-34. [PMID: 33556972 DOI: 10.1055/a-1340-0204] [Reference Citation Analysis]
68 Goodoory VC, Houghton LA, Yiannakou Y, Black CJ, Ford AC. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00501-2. [PMID: 33957271 DOI: 10.1016/j.cgh.2021.04.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Araújo AM, Botelho PB, Ribeiro DJS, Magalhães KG, Nakano EY, Arruda SF. A multiple-strain probiotic product provides a better enzymatic antioxidant response in individuals with constipation in a double-blind randomized controlled trial. Nutrition 2021;89:111225. [PMID: 33878556 DOI: 10.1016/j.nut.2021.111225] [Reference Citation Analysis]
70 Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H. Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults. Clin Gastroenterol Hepatol 2019;17:878-86. [PMID: 29857155 DOI: 10.1016/j.cgh.2018.05.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
71 Nilholm C, Roth B, Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients 2019;11:E1662. [PMID: 31330810 DOI: 10.3390/nu11071662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
72 Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol 2018;3:252-62. [PMID: 29396034 DOI: 10.1016/S2468-1253(18)30003-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 17] [Article Influence: 20.5] [Reference Citation Analysis]
73 Parreau S, Jacques J, Dumonteil S, Palat S, Geyl S, Gondran G, Bezanahary H, Liozon E, Azaïs J, Colombie S, Jauberteau MO, Loustaud-Ratti V, Ly KH, Fauchais AL. Abdominal symptoms during Sjogren's syndrome: a pilot study. Adv Rheumatol 2021;61:5. [PMID: 33468262 DOI: 10.1186/s42358-021-00164-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc 2021;80:19-28. [PMID: 32468985 DOI: 10.1017/S0029665120006990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
75 Bennet SMP, Palsson O, Whitehead WE, Barrow DA, Törnblom H, Öhman L, Simrén M, van Tilburg MAL. Systemic cytokines are elevated in a subset of patients with irritable bowel syndrome but largely unrelated to symptom characteristics. Neurogastroenterol Motil 2018;30:e13378. [PMID: 29797382 DOI: 10.1111/nmo.13378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
76 Vork L, Keszthelyi D, van Kuijk SMJ, Quetglas EG, Törnblom H, Simrén M, Aziz Q, Corsetti M, Tack J, Mujagic Z, Leue C, Kruimel JW, Masclee AAM. Patient-Specific Stress-Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study. Clin Transl Gastroenterol 2020;11:e00209. [PMID: 32764210 DOI: 10.14309/ctg.0000000000000209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Dothel G, Barbaro MR, Raschi E, Barbara G, De Ponti F. Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert Opin Investig Drugs 2018;27:251-63. [PMID: 29451407 DOI: 10.1080/13543784.2018.1442434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity in unmedicated adolescents. Journal of Affective Disorders 2019;246:586-94. [DOI: 10.1016/j.jad.2018.12.077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
79 Wallén H, Lindfors P, Andersson E, Hedman-Lagerlöf E, Hesser H, Lindefors N, Svanborg C, Ljótsson B. Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial. BMC Gastroenterol 2021;21:289. [PMID: 34256715 DOI: 10.1186/s12876-021-01867-6] [Reference Citation Analysis]
80 Karkar R, Schroeder J, Epstein DA, Pina LR, Scofield J, Fogarty J, Kientz JA, Munson SA, Vilardaga R, Zia J. TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers. Proc SIGCHI Conf Hum Factor Comput Syst 2017;2017:6850-63. [PMID: 28516175 DOI: 10.1145/3025453.3025480] [Cited by in Crossref: 51] [Cited by in F6Publishing: 13] [Article Influence: 10.2] [Reference Citation Analysis]
81 DiVasta AD, Zimmerman LA, Vitonis AF, Fadayomi AB, Missmer SA. Overlap Between Irritable Bowel Syndrome Diagnosis and Endometriosis in Adolescents. Clin Gastroenterol Hepatol 2021;19:528-537.e1. [PMID: 32184183 DOI: 10.1016/j.cgh.2020.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
82 Rafferty AJ, Hall R, Johnston CS. A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial. J Med Internet Res 2021;23:e24134. [PMID: 33650977 DOI: 10.2196/24134] [Reference Citation Analysis]
83 Aziz I, Whitehead WE, Palsson OS, Törnblom H, Simrén M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol 2020;14:39-46. [PMID: 31893959 DOI: 10.1080/17474124.2020.1708718] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
84 Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
85 Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol 2018;113:1017-25. [PMID: 29880963 DOI: 10.1038/s41395-018-0074-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
86 Tornkvist NT, Aziz I, Whitehead WE, Sperber AD, Palsson OS, Hreinsson JP, Simrén M, Törnblom H. Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population. United European Gastroenterol J 2021. [PMID: 34599559 DOI: 10.1002/ueg2.12153] [Reference Citation Analysis]
87 Norlin A, Walter S, Icenhour A, Keita ÅV, Elsenbruch S, Bednarska O, Jones MP, Simon R, Engström M. Fatigue in irritable bowel syndrome is associated with plasma levels of TNF-α and mesocorticolimbic connectivity. Brain, Behavior, and Immunity 2021;92:211-20. [DOI: 10.1016/j.bbi.2020.11.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Bai T, Xia J, Jiang Y, Cao H, Zhao Y, Zhang L, Wang H, Song J, Hou X. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey. J Gastroenterol Hepatol. 2017;32:1018-1025. [PMID: 27862281 DOI: 10.1111/jgh.13642] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
89 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
90 Zhang Y, Bi YX, Chen J, Li S, Wu XX, Zhang L, Lin ZJ, Han S, Ding SZ. Association of Peroxiredoxin 1 and brain-derived neurotrophic factor serum levels with depression and anxiety symptoms in patients with irritable bowel syndrome. Gen Hosp Psychiatry 2021;68:59-64. [PMID: 33338736 DOI: 10.1016/j.genhosppsych.2020.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Kemppinen A, Howell C, Allgar V, Dodd M, Gregson J, Knowles C, McLaughlin J, Pandya P, Whorwell P, Markaryan E, Yiannakou Y. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Trials 2020;21:122. [PMID: 32000822 DOI: 10.1186/s13063-020-4069-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
92 Lei WY, Chang WC, Wen SH, Yi CH, Liu TT, Hung JS, Wong MW, Chen CL. Predicting factors of recurrence in patients with gastroesophageal reflux disease: a prospective follow-up analysis. Therap Adv Gastroenterol. 2019;12:1756284819864549. [PMID: 31391868 DOI: 10.1177/1756284819864549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Singh R, Salem A, Nanavati J, Mullin GE. The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review. Gastroenterol Clin North Am 2018;47:107-37. [PMID: 29413008 DOI: 10.1016/j.gtc.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
94 Jones MP, Shah A, Ben-Jacob R, Talley NJ, Hansen T, Walker MM, Gray M, Koloski NA, Holtmann G. Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases. Neurogastroenterol Motil 2021;33:e14091. [PMID: 33512740 DOI: 10.1111/nmo.14091] [Reference Citation Analysis]
95 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
96 Shin A, Chang L. The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00696-0. [PMID: 34214681 DOI: 10.1016/j.cgh.2021.06.032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021; 160: 99-114. e3. [PMID: 32294476 DOI: 10.1053/j.gastro.2020.04.014] [Cited by in Crossref: 112] [Cited by in F6Publishing: 127] [Article Influence: 56.0] [Reference Citation Analysis]
98 Suzuki S, Gotoda T, Kusano C, Ikehara H, Miyakoshi Y, Fujii K. Effect of Ubiquinol Intake on Defecation Frequency and Stool Form: A Prospective, Double-Blinded, Randomized Control Study. J Med Food 2019;22:81-6. [PMID: 30192695 DOI: 10.1089/jmf.2018.4233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 Michalak A, Mosińska P, Fichna J. Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Front Pharmacol 2016;7:459. [PMID: 27990120 DOI: 10.3389/fphar.2016.00459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
100 Yoshioka T, Takeshita E, Sakata Y, Hara M, Akutagawa K, Sakata N, Endo H, Ohyama T, Matsunaga K, Tanaka Y, Shirai S, Ito Y, Tsuruoka N, Iwakiri R, Kusano M, Fujimoto K. Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups. Esophagus 2017;14:249-53. [PMID: 28725170 DOI: 10.1007/s10388-017-0573-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
101 Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clin Gastroenterol Hepatol 2020;18:392-398.e2. [PMID: 31154027 DOI: 10.1016/j.cgh.2019.05.037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
102 Xu S, Chen C, Ouyang Z, Duan C, Xu Z, Bai T, Hou X. Association between multiple sleep dimensions and functional bowel disorders among Chinese college freshmen. Sleep Med 2021:S1389-9457(21)00294-X. [PMID: 34312082 DOI: 10.1016/j.sleep.2021.05.015] [Reference Citation Analysis]
103 Moezi P, Salehi A, Molavi H, Poustchi H, Gandomkar A, Imanieh MH, Malekzadeh R. Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran. Middle East J Dig Dis. 2018;10:75-83. [PMID: 30013755 DOI: 10.15171/mejdd.2018.94] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
104 Bin Abdulrahman KA, Alenazi NS, Albishri SB, Alshehri FF, Raggi A. Association of Migraine and Irritable Bowel Syndrome in Saudi Arabia: A Nationwide Survey. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/8690562] [Reference Citation Analysis]
105 Jehangir A, Parkman HP. Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment. World J Gastroenterol 2017; 23(40): 7310-7320 [PMID: 29142478 DOI: 10.3748/wjg.v23.i40.7310] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
106 Zacharakis G, Al-Ghamdi S, AlZahrani J, Almasoud A, Arahmane O, AlShehri A, Alharbi MH, Alsalmi MM, Alotibi SB, Algaradi YA, Alsadiq FN, Nikolaidis P. Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice. Korean J Gastroenterol 2020;76:304-13. [PMID: 33361706 DOI: 10.4166/kjg.2020.110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Almario CV, Eberlein S, Khalil C, Spiegel BMR. Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14145. [PMID: 33797116 DOI: 10.1111/nmo.14145] [Reference Citation Analysis]
108 Vodnar DC, Călinoiu LF, Mitrea L, Precup G, Bindea M, Păcurar AM, Szabo K, Ştefănescu BE. A New Generation of Probiotic Functional Beverages Using Bioactive Compounds From Agro-Industrial Waste. Functional and Medicinal Beverages. Elsevier; 2019. pp. 483-528. [DOI: 10.1016/b978-0-12-816397-9.00015-7] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
109 Sperber AD. Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective. Gastroenterol Clin North Am 2021;50:489-503. [PMID: 34304784 DOI: 10.1016/j.gtc.2021.04.001] [Reference Citation Analysis]
110 Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, Festen EAM, Wijmenga C, Jonkers DMAE, Dijkstra G, Fu J, Zhernakova A, Imhann F, Weersma RK. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 2021;13:1943288. [PMID: 34313538 DOI: 10.1080/19490976.2021.1943288] [Reference Citation Analysis]
111 Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota. J Dig Dis. 2019;20:401-408. [PMID: 31070838 DOI: 10.1111/1751-2980.12756] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
112 Skonieczna-Żydecka K, Stachowska E, Maciejewska D, Ryterska K, Palma J, Czerwińska-Rogowska M, Kaczmarczyk M, Gudan A, Mruk H, Świniarska B, Kałduńska J, Stachowska Z, Mijal P, Mazur T, Kupczyński M, Marlicz W. The Digestive Health among Participants of the Woodstock Rock Festival in Poland-A Cross-Sectional Survey. Int J Environ Res Public Health 2018;15:E2256. [PMID: 30326654 DOI: 10.3390/ijerph15102256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
113 Singh P, Lee HN, Rangan V, Ballou S, Lembo J, Katon J, McMahon C, Friedlander D, Iturrino J, Nee J, Lembo A. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol 2020;18:399-405.e1. [PMID: 31442602 DOI: 10.1016/j.cgh.2019.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
114 Fuentes IM, Christianson JA. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil 2016;28:1613-8. [PMID: 27781369 DOI: 10.1111/nmo.12979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
115 Fairbrass KM, Selinger CP, Gracie DJ, Ford AC. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Neurogastroenterol Motil 2021;:e14256. [PMID: 34472157 DOI: 10.1111/nmo.14256] [Reference Citation Analysis]
116 Jehangir A, Parkman HP. Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit. Am J Gastroenterol. 2019;114:945-953. [PMID: 30865015 DOI: 10.14309/ajg.0000000000000181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
117 Drossman DA. Functional gastrointestinal disorders: what's new for Rome IV? Lancet Gastroenterol Hepatol 2016;1:6-8. [PMID: 28404114 DOI: 10.1016/S2468-1253(16)30022-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
118 Hasler WL, Li B, Koch KL, Parkman HP, Kovacic K, Mccallum RW. Methodologic considerations for studies of chronic nausea and vomiting in adults and children. Autonomic Neuroscience 2017;202:28-39. [DOI: 10.1016/j.autneu.2016.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
119 Schawkat K, Heinrich H, Parker HL, Barth BK, Mathew RP, Weishaupt D, Fox M, Reiner CS. How to define pathologic pelvic floor descent in MR defecography during defecation? Abdom Radiol 2018;43:3233-40. [DOI: 10.1007/s00261-018-1652-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
120 Saha S, Mara K, Pardi DS, Khanna S. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology 2021;160:1961-1969.e3. [PMID: 33444573 DOI: 10.1053/j.gastro.2021.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
121 Almario CV, Chey WD, Spiegel BMR. Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors. Am J Gastroenterol. 2020;115:1707-1715. [PMID: 32852340 DOI: 10.14309/ajg.0000000000000798] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 32.5] [Reference Citation Analysis]
122 Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology 2020;5:117-31. [DOI: 10.1016/s2468-1253(19)30324-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 16.5] [Reference Citation Analysis]
123 Nilholm C, Larsson E, Roth B, Gustafsson R, Ohlsson B. Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients. Nutrients 2019;11:E1279. [PMID: 31195706 DOI: 10.3390/nu11061279] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
124 Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
125 Vervier K, Moss S, Kumar N, Adoum A, Barne M, Browne H, Kaser A, Kiely CJ, Neville BA, Powell N, Raine T, Stares MD, Zhu A, De La Revilla Negro J, Lawley TD, Parkes M. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut 2021:gutjnl-2021-325177. [PMID: 34810234 DOI: 10.1136/gutjnl-2021-325177] [Reference Citation Analysis]
126 Silviera M, Keller DS. Pelvic Floor Dysfunction. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Elsevier; 2019. pp. 1750-60. [DOI: 10.1016/b978-0-323-40232-3.00150-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
127 Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology 2020;158:1262-1273.e3. [PMID: 31917991 DOI: 10.1053/j.gastro.2019.12.021] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 42.5] [Reference Citation Analysis]
128 Black CJ. Review article: Diagnosis and investigation of irritable bowel syndrome. Aliment Pharmacol Ther 2021;54 Suppl 1:S33-43. [PMID: 34927756 DOI: 10.1111/apt.16597] [Reference Citation Analysis]
129 Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Curr Med Res Opin 2021;37:567-78. [PMID: 33566707 DOI: 10.1080/03007995.2021.1888705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Zhang Y, Zhang L, Li S, Wu XX, Bi YX, Hu X, Chen YQ, Yuan Y. Serum levels of high sensitive C-reactive protein and tumor necrosis factor-alpha in different subtypes of irritable bowel syndrome and their correlation. Shijie Huaren Xiaohua Zazhi 2020; 28(16): 782-788 [DOI: 10.11569/wcjd.v28.i16.782] [Reference Citation Analysis]
131 Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome. Nutrients 2021;13:416. [PMID: 33525489 DOI: 10.3390/nu13020416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
132 Saidi K, Nilholm C, Roth B, Ohlsson B. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr Res 2021;86:23-36. [PMID: 33450656 DOI: 10.1016/j.nutres.2020.12.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Gan WC, Smith L, Luca EJ, Harnett JE. The prevalence and characteristics of complementary medicine use by Australian and American adults living with gastrointestinal disorders: A systematic review. Complementary Therapies in Medicine 2018;41:52-60. [DOI: 10.1016/j.ctim.2018.08.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
134 Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current Opinion in Clinical Nutrition & Metabolic Care 2017;20:456-63. [DOI: 10.1097/mco.0000000000000416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
135 Blackett JW, Li J, Jodorkovsky D, Freedberg DE. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Neurogastroenterol Motil 2021;:e14251. [PMID: 34468069 DOI: 10.1111/nmo.14251] [Reference Citation Analysis]
136 Mohamadi J, Ghazanfari F, Drikvand FM. Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial. Psychiatr Q 2019;90:565-78. [DOI: 10.1007/s11126-019-09643-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
137 Serra J, Pohl D, Azpiroz F, Chiarioni G, Ducrotté P, Gourcerol G, Hungin APS, Layer P, Mendive JM, Pfeifer J, Rogler G, Scott SM, Simrén M, Whorwell P; Functional Constipation Guidelines Working Group. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterol Motil 2020;32:e13762. [PMID: 31756783 DOI: 10.1111/nmo.13762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
138 Dimidi E, Cox C, Grant R, Scott SM, Whelan K. Perceptions of Constipation Among the General Public and People With Constipation Differ Strikingly From Those of General and Specialist Doctors and the Rome IV Criteria. Am J Gastroenterol 2019;114:1116-29. [DOI: 10.14309/ajg.0000000000000267] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
139 Deb C, Campion S, Derrick V, Ruiz V, Abomoelak B, Avdella A, Zou B, Horvath K, Mehta DI. Sucrase-isomaltase Gene Variants in Patients With Abnormal Sucrase Activity and Functional Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr. 2021;72:29-35. [PMID: 32732636 DOI: 10.1097/mpg.0000000000002852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Mehta V, Mehta A, Patel S, Irastorza L, Rizvi SA, Abomoelak B, Mehta N, Mehta D. Efficacy of Short Course of Preksha Dhyana for Functional Abdominal Pain Disorder in a Busy Pediatric Clinic. Front Pediatr 2021;9:646686. [PMID: 34113586 DOI: 10.3389/fped.2021.646686] [Reference Citation Analysis]
141 Schmulson M. How to use Rome IV criteria in the evaluation of esophageal disorders. Curr Opin Gastroenterol. 2018;34:258-265. [PMID: 29846258 DOI: 10.1097/mog.0000000000000443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
142 Zejnelagic J, Ohlsson B. Chronic stress and poor sleeping habits are associated with self-reported IBS and poor psychological well-being in the general population. BMC Res Notes 2021;14:280. [PMID: 34294119 DOI: 10.1186/s13104-021-05688-4] [Reference Citation Analysis]
143 Zielińska M, Fichna J, Bashashati M, Habibi S, Sibaev A, Timmermans JP, Storr M. G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain. Neurogastroenterol Motil 2017;29. [PMID: 28191706 DOI: 10.1111/nmo.13025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
144 Zhou Q, Verne GN. Are the Rome Criteria a Sound Standard for Gastrointestinal Disorders Worldwide? Gastroenterology 2020;158:1212-4. [PMID: 32061864 DOI: 10.1053/j.gastro.2020.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Black CJ, Yiannakou Y, Houghton LA, Shuweihdi F, West R, Guthrie E, Ford AC. Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13872] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
146 Kim O, Cha C, Jeong H, Cho M, Kim B. Influence of Irritable Bowel Syndrome on Stress and Depressive Symptoms in Nurses: The Korea Nurses' Health Study. Int J Environ Res Public Health 2021;18:12324. [PMID: 34886050 DOI: 10.3390/ijerph182312324] [Reference Citation Analysis]
147 El-Salhy M, Gilja OH, Hatlebakk JG. Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. Mol Med Rep. 2019;20:787-794. [PMID: 31180516 DOI: 10.3892/mmr.2019.10284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
148 Tsai YJ, Yang YW, Lan YT. Translation and validation of the traditional Chinese version of the Constipation Severity Instrument. J Chin Med Assoc 2021;84:299-302. [PMID: 33230063 DOI: 10.1097/JCMA.0000000000000462] [Reference Citation Analysis]
149 Gajdos P, Román N, Tóth-Király I, Rigó A. Functional gastrointestinal symptoms and increased risk for orthorexia nervosa. Eat Weight Disord 2021. [PMID: 34170490 DOI: 10.1007/s40519-021-01242-0] [Reference Citation Analysis]
150 Peralta-palmezano JJ, Guerrero-lozano R. The water load test in school children and adolescents with functional gastrointestinal disorders. Indian J Gastroenterol 2021;40:162-8. [DOI: 10.1007/s12664-020-01073-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:1485-94. [PMID: 33840729 DOI: 10.14309/ajg.0000000000001247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Yang M, Feng Y, Zhang YL, Smith CM, Hou YN, Wang H, Deng G, Mao JJ. Herbal formula MaZiRenWan (Hemp Seed Pill) for constipation: A systematic review with meta-analysis. Phytomedicine 2021;82:153459. [PMID: 33486266 DOI: 10.1016/j.phymed.2021.153459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
153 Elli C, Novella A, Nobili A, Ianes A, Pasina L. Laxative Agents in Nursing Homes: An Example of Prescribing Cascade. J Am Med Dir Assoc 2021:S1525-8610(21)00420-5. [PMID: 34023302 DOI: 10.1016/j.jamda.2021.04.021] [Reference Citation Analysis]
154 Velasco-Benítez CA, Gómez-Oliveros LF, Rubio-Molina LM, Tovar-Cuevas JR, Saps M. Diagnostic Accuracy of the Rome IV Criteria for the Diagnosis of Functional Gastrointestinal Disorders in Children. J Pediatr Gastroenterol Nutr 2021;72:538-41. [PMID: 33394887 DOI: 10.1097/MPG.0000000000003030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Tack J, Drossman DA. What's new in Rome IV? Neurogastroenterol Motil 2017;29. [PMID: 28303651 DOI: 10.1111/nmo.13053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
156 Robin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, Di Lorenzo C, Shulman RJ, Hyams JS, Palsson O, van Tilburg MAL. Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. J Pediatr. 2018;195:134-139. [PMID: 29398057 DOI: 10.1016/j.jpeds.2017.12.012] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 21.5] [Reference Citation Analysis]
157 Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 2020;28:23-33. [DOI: 10.1007/s00520-019-05016-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
158 Josefsson A, Palsson O, Simrén M, Sperber AD, Törnblom H, Whitehead W. Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population. United European Gastroenterol J 2018;6:1461-9. [PMID: 30574316 DOI: 10.1177/2050640618798894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Davies A, Leach C, Butler C, Gregory A, Henshaw S, Minton O, Shorthose K, Batsari KM. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features. Pain 2021;162:309-18. [PMID: 32701649 DOI: 10.1097/j.pain.0000000000002024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
160 Hagan M, Hayee BH, Rodriguez-Mateos A. (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review. Molecules 2021;26:1843. [PMID: 33805938 DOI: 10.3390/molecules26071843] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
161 Carrington EV, Popa SL, Chiarioni G. Proctalgia Syndromes: Update in Diagnosis and Management. Curr Gastroenterol Rep 2020;22:35. [PMID: 32519087 DOI: 10.1007/s11894-020-00768-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Stenlund H, Nilholm C, Chorell E, Roth B, D'Amato M, Ohlsson B. Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet. Metabolites 2021;11:440. [PMID: 34357334 DOI: 10.3390/metabo11070440] [Reference Citation Analysis]
163 Arishi AM, Elmakki EE, Hakami OM, Alganmy OM, Maashi SM, Al-Khairat HK, Sahal YA, Sharif AA, Alfaifi MH. Irritable Bowel Syndrome: Prevalence and Risk Factors in Jazan Region, Saudi Arabia. Cureus 2021;13:e15979. [PMID: 34336470 DOI: 10.7759/cureus.15979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Shields AL, Lamoureux RE, Taylor F, Barth JA, Mulberg AE, Kessler V, Skuban N. FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument. Qual Life Res 2021. [PMID: 33914257 DOI: 10.1007/s11136-021-02847-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Muñoz-Duyos A, Lagares-Tena L, Ribas Y, Baanante JC, Navarro-Luna A. Critical appraisal of international guidelines for the management of fecal incontinence in adults: is it possible to define what to do in different clinical scenarios? Tech Coloproctol 2021. [PMID: 34767095 DOI: 10.1007/s10151-021-02544-2] [Reference Citation Analysis]
166 Liu XJ, Xie WR, Wu LH, Ye ZN, Zhang XY, Zhang R, He XX. Changes in oral flora of patients with functional dyspepsia. Sci Rep 2021;11:8089. [PMID: 33850203 DOI: 10.1038/s41598-021-87600-5] [Reference Citation Analysis]
167 Whitehead WE, Palsson OS, Simrén M. Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management? Expert Rev Gastroenterol Hepatol 2017;11:281-3. [PMID: 28276814 DOI: 10.1080/17474124.2017.1292130] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
168 Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, David Tai FW, Afify S, Aziz I. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31221-0. [PMID: 32882424 DOI: 10.1016/j.cgh.2020.08.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
169 Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150:1257-1261. [PMID: 27147121 DOI: 10.1053/j.gastro.2016.03.035] [Cited by in Crossref: 462] [Cited by in F6Publishing: 365] [Article Influence: 115.5] [Reference Citation Analysis]
170 Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. The Lancet 2020;396:1664-74. [DOI: 10.1016/s0140-6736(20)32115-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
171 Dimidi E, Whelan K. Food supplements and diet as treatment options in irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13951. [PMID: 32697018 DOI: 10.1111/nmo.13951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
172 Tack J, Masuy I, Van Den Houte K, Wauters L, Schol J, Vanuytsel T, Vandenberghe A, Carbone F. Drugs under development for the treatment of functional dyspepsia and related disorders. Expert Opinion on Investigational Drugs 2019;28:871-89. [DOI: 10.1080/13543784.2019.1673365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
173 Pop LL, Mureşan IA, Dumitraşcu DL. How much bloating in the irritable bowel syndrome? Rom J Intern Med 2018;56:221-6. [PMID: 29894305 DOI: 10.2478/rjim-2018-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Drossman DA, Tack J. Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction. Gastroenterology 2021:S0016-5085(21)03794-X. [PMID: 34808139 DOI: 10.1053/j.gastro.2021.11.019] [Reference Citation Analysis]
175 Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson's Disease. J Clin Med 2021;10:493. [PMID: 33572547 DOI: 10.3390/jcm10030493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
176 Polster AV, Palsson OS, Törnblom H, Öhman L, Sperber AD, Whitehead WE, Simrén M. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study. Neurogastroenterol Motil 2019;31:e13483. [PMID: 30393924 DOI: 10.1111/nmo.13483] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
177 Meinds RJ, Timmerman MEW, van Meegdenburg MM, Trzpis M, Broens PMA. Reproducibility, feasibility and validity of the Groningen Defecation and Fecal Continence questionnaires. Scand J Gastroenterol 2018;53:790-6. [PMID: 29703095 DOI: 10.1080/00365521.2018.1465993] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
178 Papaefthymiou A, Doulberis M, Kountouras J, Kolokytha C, Galanopoulos M, Liatsos C, Kyriakos N, Giakoumis M, Papadomichelakis M, Polyzos SA, Kotronis G, Katsinelos P. Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey. Eur J Gastroenterol Hepatol 2019;31:954-63. [PMID: 31107738 DOI: 10.1097/MEG.0000000000001439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Whitehead WE, Palsson OS, Simrén M. Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation. Neurogastroenterol Motil 2016;28:783-92. [PMID: 27214096 DOI: 10.1111/nmo.12852] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
180 Bjørsum-Meyer T, Christensen P, Baatrup G, Jakobsen MS, Asmussen J, Qvist N. Dyssynergic patterns of defecation in constipated adolescents and young adults with anorectal malformations. Sci Rep 2020;10:19673. [PMID: 33184420 DOI: 10.1038/s41598-020-76841-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]